LOGIN  |  REGISTER

List of Medical Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 133.70
-0.74 -0.55
6.13M
1.74B
US$ 232.640B
US$ 534.71
-9.76 -1.79
1.11M
356.18M
US$ 190.450B
US$ 418.70
-10.63 -2.48
2.23M
377.49M
US$ 158.060B
US$ 103.83
-0.49 -0.47
5.49M
1.48B
US$ 153.670B
US$ 392.51
-2.77 -0.70
1.24M
382.16M
US$ 150.000B
US$ 199.63
-3.57 -1.76
2.32M
715.67M
US$ 142.870B
US$ 87.67
-0.72 -0.81
7.13M
1.28B
US$ 112.220B
US$ 735.33
16.03 2.23
964,225
124.90M
US$ 91.840B
US$ 172.95
-3.21 -1.82
2.47M
286.61M
US$ 49.570B
US$ 76.69
-0.10 -0.13
2.41M
586.60M
US$ 44.990B
US$ 545.56
-1.45 -0.27
435,835
81.88M
US$ 44.670B
US$ 86.80
-0.98 -1.12
2.41M
494.62M
US$ 42.930B
US$ 167.63
2.70 1.64
1.81M
238.68M
US$ 40.010B
US$ 256.41
-0.55 -0.21
783,459
146.63M
US$ 37.600B
US$ 119.25
-2.13 -1.75
1.42M
284.06M
US$ 33.870B
US$ 82.94
0.01 0.01
2.59M
390.60M
US$ 32.400B
US$ 162.45
-1.79 -1.09
1.47M
173.00M
US$ 28.100B
US$ 1.00
-20.54 -1.70
119,042
20.78M
US$ 24.700B
US$ 233.32
-4.23 -1.78
503,949
98.37M
US$ 22.950B
US$ 257.87
-4.02 -1.53
546,044
83.70M
US$ 21.580B
US$ 300.70
-0.35 -0.12
579,330
70.14M
US$ 21.090B
US$ 158.69
-3.07 -1.90
733,567
132.02M
US$ 20.950B
US$ 346.73
-3.49 -1.00
391,820
59.51M
US$ 20.630B
US$ 173.97
-2.95 -1.67
632,274
111.64M
US$ 19.420B
US$ 92.57
-1.10 -1.17
1.74M
197.85M
US$ 18.310B
US$ 221.48
-0.78 -0.35
392,287
71.85M
US$ 15.910B
US$ 97.15
-3.65 -3.62
2.83M
158.60M
US$ 15.410B
US$ 29.69
-1.32 -4.26
4.77M
513.18M
US$ 15.240B
US$ 73.29
-0.01 -0.01
3.50M
199.51M
US$ 14.620B
US$ 64.37
-0.41 -0.63
1.69M
225.72M
US$ 14.530B
US$ 29.94
-0.34 -1.12
906,114
437.53M
US$ 13.100B
US$ 147.59
-2.51 -1.67
1.12M
82.56M
US$ 12.190B
US$ 98.71
-2.60 -2.57
991,610
117.87M
US$ 11.630B
US$ 47.53
-0.81 -1.68
766,197
216.56M
US$ 10.290B
US$ 318.90
-2.60 -0.81
368,774
31.08M
US$ 9.910B
US$ 52.48
-0.88 -1.65
1.73M
185.08M
US$ 9.710B
US$ 248.37
-2.69 -1.07
259,867
38.73M
US$ 9.620B
US$ 58.10
-2.87 -4.71
8.17M
152.40M
US$ 8.850B
US$ 162.45
-5.12 -3.06
819,338
53.54M
US$ 8.700B
US$ 153.90
-3.22 -2.05
691,556
49.12M
US$ 7.560B
US$ 124.43
-3.04 -2.38
414,062
56.03M
US$ 6.970B
US$ 55.97
-3.20 -5.41
2.16M
112.95M
US$ 6.320B
US$ 41.27
-1.18 -2.78
3.61M
151.60M
US$ 6.260B
US$ 49.54
-0.96 -1.90
2.39M
123.56M
US$ 6.120B
US$ 101.46
-2.04 -1.97
954,383
57.14M
US$ 5.800B
US$ 79.19
-1.23 -1.53
688,585
69.53M
US$ 5.510B
US$ 247.06
-4.50 -1.79
485,895
22.14M
US$ 5.470B
US$ 91.12
-2.46 -2.63
468,579
58.28M
US$ 5.310B
US$ 116.67
-3.23 -2.69
450,795
44.19M
US$ 5.160B
US$ 13.81
-0.07 -0.50
1.39M
353.40M
US$ 4.880B
US$ 79.97
0.00 0.00
0
58.56M
US$ 4.680B
US$ 139.22
-3.25 -2.28
474,223
31.30M
US$ 4.360B
US$ 125.17
-4.02 -3.11
677,890
33.56M
US$ 4.200B
US$ 55.26
-0.94 -1.67
407,737
74.03M
US$ 4.090B
US$ 117.02
-3.98 -3.29
520,762
34.89M
US$ 4.080B
US$ 78.92
-1.06 -1.33
347,758
49.23M
US$ 3.890B
US$ 126.91
-1.57 -1.22
693,207
29.49M
US$ 3.740B
US$ 70.98
0.00 0.00
0
51.11M
US$ 3.630B
US$ 75.13
-1.74 -2.26
465,901
48.04M
US$ 3.610B
US$ 11.40
-0.35 -2.98
1.13M
283.24M
US$ 3.230B
US$ 129.71
-5.73 -4.23
186,970
24.48M
US$ 3.180B
US$ 56.97
-0.95 -1.64
576,182
54.11M
US$ 3.080B
US$ 45.58
-0.55 -1.19
496,573
54.30M
US$ 2.470B
US$ 21.37
-0.78 -3.52
1.61M
104.50M
US$ 2.230B
US$ 35.59
-2.58 -6.76
1.05M
59.58M
US$ 2.120B
US$ 29.22
-0.97 -3.21
1.30M
67.26M
US$ 1.970B
US$ 82.98
-1.41 -1.67
106,391
22.48M
US$ 1.870B
US$ 16.89
-0.82 -4.63
875,141
108.20M
US$ 1.830B
US$ 51.93
-2.40 -4.42
425,672
30.89M
US$ 1.600B
US$ 10.93
-0.06 -0.55
1.35M
141.77M
US$ 1.550B
US$ 31.54
-0.22 -0.69
369,355
48.75M
US$ 1.540B
US$ 44.85
-1.87 -4.00
1.23M
33.60M
US$ 1.510B
US$ 31.43
-1.80 -5.42
872,152
45.69M
US$ 1.440B
US$ 30.29
-0.43 -1.40
297,408
47.04M
US$ 1.420B
US$ 46.11
2.57 5.90
694,490
28.76M
US$ 1.330B
US$ 9.25
-0.07 -0.75
1.33M
134.56M
US$ 1.240B
US$ 24.35
-0.24 -0.98
220,741
49.60M
US$ 1.210B
US$ 15.10
-0.06 -0.40
860,785
76.25M
US$ 1.150B
US$ 13.09
0.00 0.00
0
83.72M
US$ 1.100B
US$ 20.45
-0.45 -2.15
223,444
52.94M
US$ 1.080B
US$ 4.98
-0.35 -6.57
6.36M
216.94M
US$ 1.080B
US$ 16.25
-0.53 -3.16
2.21M
65.68M
US$ 1.070B
US$ 21.81
-1.03 -4.51
492,656
46.39M
US$ 1.010B
US$ 18.45
-0.79 -4.11
641,090
53.63M
US$ 989.470M
US$ 12.75
-0.74 -5.49
938,110
77.16M
US$ 983.790M
US$ 15.81
0.51 3.33
267,097
61.52M
US$ 972.630M
US$ 6.48
0.14 2.21
1.11M
146.95M
US$ 952.240M
US$ 7.31
-0.24 -3.18
1.48M
128.36M
US$ 938.310M
US$ 1.34
-0.02 -1.47
2.29M
672.80M
US$ 901.550M
US$ 16.61
-1.25 -7.00
927,050
49.28M
US$ 818.540M
US$ 18.02
-0.45 -2.44
351,033
41.94M
US$ 755.550M
US$ 59.02
-2.78 -4.50
58,092
12.67M
US$ 747.780M
US$ 8.66
-0.55 -5.97
853,736
76.61M
US$ 663.440M
US$ 17.20
-1.73 -9.14
387,367
35.82M
US$ 616.100M
US$ 19.29
-0.77 -3.84
298,864
30.59M
US$ 590.080M
US$ 11.83
-0.52 -4.21
406,562
46.24M
US$ 547.020M
US$ 19.46
-0.84 -4.14
563,182
28.01M
US$ 545.070M
US$ 21.24
-1.24 -5.52
135,610
24.22M
US$ 514.430M
US$ 12.60
-0.45 -3.45
850,022
40.30M
US$ 507.780M
US$ 11.36
0.43 3.93
1.06M
44.01M
US$ 499.950M
US$ 5.29
-0.31 -5.54
1.34M
91.04M
US$ 481.600M
US$ 1.28
-0.07 -5.19
1.82M
372.26M
US$ 476.490M
US$ 3.29
-0.08 -2.37
53,671
139.82M
US$ 460.010M
US$ 6.82
-0.20 -2.85
418,866
65.37M
US$ 445.820M
US$ 12.24
-0.45 -3.55
677,608
36.20M
US$ 443.090M
US$ 3.40
-0.36 -9.57
738,759
128.81M
US$ 437.950M
US$ 1.48
-0.12 -7.50
6.82M
294.32M
US$ 435.590M
US$ 29.66
-0.33 -1.10
101,676
14.29M
US$ 423.840M
US$ 1.88
-0.06 -3.09
3.59M
220.86M
US$ 415.220M
US$ 10.72
-0.40 -3.60
342,008
38.21M
US$ 409.610M
US$ 16.47
-0.54 -3.17
62,032
23.48M
US$ 386.720M
US$ 6.05
-0.13 -2.10
436,413
62.30M
US$ 376.920M
US$ 9.19
-0.39 -4.07
476,551
40.47M
US$ 371.920M
US$ 38.95
-1.50 -3.71
643,620
9.27M
US$ 361.070M
C$ 2.24
0.00 0.00
0
154.17M
C$ 345.340M
US$ 8.36
-0.44 -5.00
251,952
41.23M
US$ 344.680M
US$ 6.30
-0.68 -9.74
529,548
49.57M
US$ 312.290M
US$ 10.22
-0.17 -1.64
221,220
29.85M
US$ 305.070M
US$ 3.26
0.001 0.03
1.93M
92.44M
US$ 301.450M
US$ 5.12
-0.20 -3.76
1.07M
58.52M
US$ 299.620M
US$ 7.86
0.09 1.16
58,412
37.43M
US$ 294.200M
US$ 0.49
-0.01 -2.69
15.94M
595.33M
US$ 291.120M
US$ 5.05
0.42 9.07
285,367
55.19M
US$ 278.710M
US$ 6.87
-0.28 -3.92
173,187
38.94M
US$ 267.520M
US$ 9.43
-0.82 -8.00
165,815
27.60M
US$ 260.270M
US$ 29.17
-0.48 -1.62
86,201
8.74M
US$ 254.950M
US$ 1.84
-0.30 -14.02
16.26M
138.40M
US$ 254.660M
US$ 13.37
0.13 0.98
56,738
18.82M
US$ 251.620M
US$ 28.00
0.00 0.00
0
8.53M
US$ 238.840M
US$ 9.87
-0.26 -2.57
266,167
24.00M
US$ 236.880M
C$ 0.82
0.00 0.00
80,476
285.12M
C$ 233.800M
US$ 3.44
-0.24 -6.52
7.28M
67.59M
US$ 232.510M
US$ 2.17
-0.07 -3.12
620,864
105.48M
US$ 228.890M
US$ 3.05
-0.03 -0.97
555,876
74.59M
US$ 227.500M
US$ 6.41
-0.24 -3.61
376,927
34.82M
US$ 223.200M
US$ 5.84
0.00 0.00
0
37.47M
US$ 218.820M
US$ 3.49
0.09 2.65
1.37M
55.65M
US$ 194.220M
US$ 57.19
-1.25 -2.14
25,180
3.39M
US$ 193.870M
US$ 6.09
0.11 1.84
95,956
30.03M
US$ 182.880M
US$ 2.14
-0.06 -2.73
271,559
84.73M
US$ 181.320M
US$ 3.48
-0.74 -17.46
278,492
50.40M
US$ 175.140M
US$ 7.26
-0.23 -3.07
164,874
23.82M
US$ 172.930M
US$ 20.12
-0.66 -3.18
197,303
8.46M
US$ 170.220M
US$ 3.67
0.05 1.38
279,405
45.84M
US$ 168.230M
US$ 6.59
0.01 0.15
136,620
24.26M
US$ 159.870M
US$ 4.96
-0.11 -2.17
55,079
30.49M
US$ 151.230M
US$ 46.22
-1.60 -3.35
111,522
3.26M
US$ 150.680M
US$ 12.84
-0.32 -2.43
84,087
11.61M
US$ 149.070M
US$ 8.64
0.11 1.29
261,753
16.52M
US$ 142.730M
US$ 5.17
-0.25 -4.61
287,710
26.22M
US$ 135.560M
US$ 1.34
-0.08 -5.63
985,735
100.56M
US$ 134.750M
US$ 6.25
0.09 1.46
165,866
21.26M
US$ 132.880M
US$ 3.49
-0.14 -3.86
75,766
37.72M
US$ 131.640M
US$ 3.48
-0.32 -8.42
256,629
35.94M
US$ 125.070M
US$ 6.96
-0.09 -1.28
66,779
17.64M
US$ 122.770M
US$ 2.14
-0.05 -2.28
54,003
49.50M
US$ 105.930M
US$ 2.64
-0.14 -5.04
214,935
39.49M
US$ 104.250M
US$ 2.91
0.01 0.34
141,825
34.31M
US$ 99.840M
US$ 2.58
0.29 12.66
271,107
37.64M
US$ 97.110M
US$ 15.44
-0.16 -1.03
27,520
6.27M
US$ 96.800M
US$ 0.67
-0.03 -3.87
254,938
139.01M
US$ 92.440M
US$ 0.58
-0.07 -10.17
267,463
156.55M
US$ 90.020M
US$ 8.01
-0.20 -2.44
43,676
10.64M
US$ 85.190M
US$ 2.51
0.11 4.58
244,521
31.85M
US$ 79.940M
US$ 2.42
-0.07 -2.81
222,698
32.80M
US$ 79.380M
US$ 1.93
-0.11 -5.39
53,994
39.39M
US$ 76.020M
US$ 4.59
-0.07 -1.50
80,635
16.39M
US$ 75.230M
US$ 1.27
0.01 0.79
55,101
59.23M
US$ 75.220M
US$ 1.74
-0.04 -2.25
431,389
43.09M
US$ 74.980M
US$ 3.27
-0.01 -0.30
64,516
22.00M
US$ 71.940M
US$ 2.51
-0.09 -3.46
1.19M
28.03M
US$ 70.360M
US$ 3.93
-0.06 -1.50
61,366
17.54M
US$ 68.930M
US$ 2.04
0.01 0.49
373,442
33.70M
US$ 68.750M
US$ 2.05
-0.04 -1.91
425,092
32.02M
US$ 65.640M
US$ 0.68
-0.06 -8.65
1.50M
95.97M
US$ 64.880M
US$ 1.29
-0.07 -5.15
709,360
49.57M
US$ 63.950M
US$ 3.50
0.00 0.00
0
18.00M
US$ 63.000M
US$ 2.08
-0.01 -0.48
25,906
30.25M
US$ 62.920M
US$ 1.03
-0.06 -5.50
196,110
60.93M
US$ 62.760M
C$ 0.55
-0.04 -6.78
25,000
113.80M
C$ 62.590M
US$ 3.40
0.13 3.98
29,640
18.34M
US$ 62.360M
US$ 1.05
0.02 1.94
1.37M
59.34M
US$ 62.310M
US$ 2.07
0.00 0.00
3,366
29.25M
US$ 60.550M
US$ 1.06
0.00 0.00
962,094
56.57M
US$ 59.960M
US$ 1.59
-0.004 -0.25
43,631
37.10M
US$ 58.840M
US$ 2.22
-0.02 -0.89
217,333
26.08M
US$ 57.900M
US$ 2.72
0.04 1.49
638,927
20.75M
US$ 56.440M
C$ 0.21
0.02 7.69
209,151
253.70M
C$ 53.280M
US$ 0.68
0.01 1.49
523,884
77.89M
US$ 52.970M
US$ 20.01
0.00 0.00
0
2.54M
US$ 50.830M
US$ 5.02
1.10 28.06
7,621
10.07M
US$ 50.550M
US$ 0.12
0.002 1.77
928,872
417.59M
US$ 48.020M
C$ 0.39
-0.005 -1.28
90,664
119.77M
C$ 46.110M
US$ 0.77
-0.04 -4.38
298,999
57.89M
US$ 44.290M
US$ 4.08
0.05 1.24
129,613
10.54M
US$ 43.000M
US$ 7.72
0.11 1.45
20,477
5.28M
US$ 40.760M
US$ 0.28
0.0044 1.62
637,815
145.47M
US$ 40.150M
US$ 6.09
-0.02 -0.33
152,552
6.55M
US$ 39.890M
US$ 9.40
0.00 0.00
68,810
3.73M
US$ 35.060M
US$ 1.55
0.36 30.25
4.29M
22.45M
US$ 34.800M
US$ 1.30
0.00 0.00
124,671
26.67M
US$ 34.670M
US$ 3.98
-0.01 -0.25
5,963
8.27M
US$ 32.910M
US$ 2.04
0.00 0.00
0
15.37M
US$ 31.350M
US$ 7.11
6.91 3.00
109,684
4.37M
US$ 31.070M
C$ 0.34
-0.01 -2.86
2,000
90.89M
C$ 30.900M
US$ 5.17
0.74 16.70
1.44M
5.89M
US$ 30.450M
US$ 1.48
-0.09 -5.73
45,916
20.24M
US$ 29.960M
US$ 3.47
0.06 1.76
873
8.53M
US$ 29.560M
US$ 0.73
-0.0012 -0.16
158,417
40.14M
US$ 29.260M
C$ 0.27
0.005 1.92
108,000
103.95M
C$ 27.550M
C$ 0.24
-0.005 -2.04
1.12M
113.22M
C$ 27.170M
US$ 0.70
-0.0048 -0.68
170,017
38.39M
US$ 26.870M
C$ 0.09
0.00 0.00
0
293.11M
C$ 24.910M
C$ 0.32
0.00 0.00
0
77.42M
C$ 24.770M
US$ 0.73
0.03 4.28
276,118
30.84M
US$ 22.540M
C$ 0.13
0.005 4.00
197,000
166.00M
C$ 21.580M
US$ 0.93
-0.0023 -0.25
190,343
22.90M
US$ 21.270M
US$ 13.98
1.93 16.02
56,649
1.48M
US$ 20.690M
US$ 0.74
-0.02 -2.00
333,826
27.52M
US$ 20.230M
US$ 2.72
0.15 5.84
138,818
7.26M
US$ 19.750M
US$ 0.66
0.008 1.23
36,298
29.94M
US$ 19.700M
US$ 0.44
-0.01 -2.21
1.77M
43.62M
US$ 19.320M
US$ 2.53
0.02 0.80
626,397
7.46M
US$ 18.870M
US$ 2.64
-0.01 -0.38
21,989
6.79M
US$ 17.930M
US$ 1.02
0.09 9.68
299,195
16.64M
US$ 16.970M
US$ 0.31
0.00 0.00
0
52.24M
US$ 16.390M
US$ 1.17
-0.07 -5.65
143,689
13.96M
US$ 16.330M
C$ 0.05
0.00 0.00
0
320.55M
C$ 16.030M
US$ 2.67
0.00 0.00
0
5.89M
US$ 15.730M
C$ 0.25
-0.02 -5.77
19,500
60.55M
C$ 14.830M
US$ 0.71
-0.07 -8.61
8,443
20.63M
US$ 14.670M
US$ 2.04
0.00 0.00
0
7.09M
US$ 14.440M
US$ 0.19
0.01 6.15
1.81M
72.19M
US$ 13.720M
US$ 0.41
-0.03 -6.31
68,844
31.90M
US$ 13.080M
US$ 0.98
0.02 2.07
49,186
13.30M
US$ 13.030M
C$ 0.13
0.00 0.00
0
100.02M
C$ 12.500M
C$ 0.06
0.00 0.00
0
217.73M
C$ 11.980M
US$ 5.65
-0.16 -2.67
78,042
2.05M
US$ 11.570M
US$ 0.61
0.00 0.00
0
19.01M
US$ 11.530M
US$ 0.71
0.00 0.00
43,189
14.59M
US$ 10.370M
US$ 2.37
0.04 1.72
114,930
4.17M
US$ 9.880M
US$ 0.39
0.0093 2.44
24,071
24.39M
US$ 9.510M
US$ 4.58
0.00 0.00
0
2.04M
US$ 9.340M
US$ 0.26
-0.02 -5.78
593,177
31.93M
US$ 8.330M
US$ 1.70
-0.08 -4.49
257,049
4.81M
US$ 8.180M
US$ 1.27
0.00 0.00
0
6.24M
US$ 7.920M
US$ 3.00
-0.49 -14.04
533,231
2.46M
US$ 7.380M
US$ 0.66
-0.007 -1.04
554,017
10.63M
US$ 7.050M
US$ 0.59
-0.0071 -1.19
79,024
11.07M
US$ 6.530M
US$ 0.85
-0.0001 -0.01
370,120
6.67M
US$ 5.670M
C$ 0.11
0.00 0.00
0
48.23M
C$ 5.060M
C$ 0.04
0.00 0.00
0
122.72M
C$ 4.910M
C$ 0.05
0.00 0.00
0
96.48M
C$ 4.820M
US$ 0.82
0.08 10.14
699,063
5.85M
US$ 4.770M
US$ 0.70
-2.41 -77.49
66,651
6.63M
US$ 4.630M
US$ 0.29
0.02 7.56
1.08M
15.58M
US$ 4.560M
C$ 0.05
-0.005 -10.00
2,914
101.29M
C$ 4.560M
C$ 0.01
0.00 0.00
1.85M
451.63M
C$ 4.520M
US$ 0.06
0.00 0.00
0
73.90M
US$ 4.510M
US$ 0.34
0.00 0.00
0
11.88M
US$ 4.040M
US$ 0.78
0.00 0.00
0
4.85M
US$ 3.780M
US$ 3.79
0.22 6.16
63,486
980,321
US$ 3.720M
US$ 0.92
-0.01 -1.29
465,681
3.75M
US$ 3.440M
US$ 0.55
-0.005 -0.90
1.30M
6.00M
US$ 3.290M
US$ 1.40
-0.03 -2.10
75,339
2.22M
US$ 3.110M
US$ 0.98
-0.0055 -0.56
243,556
3.14M
US$ 3.080M
US$ 0.13
-0.01 -7.14
17,294
21.04M
US$ 2.740M
US$ 0.03
-0.007 -20.00
154,900
96.71M
US$ 2.710M
US$ 1.45
0.00 0.00
0
1.82M
US$ 2.640M
US$ 0.50
0.00 0.00
0
5.24M
US$ 2.610M
US$ 1.41
-0.01 -0.70
183,465
1.77M
US$ 2.500M
US$ 4.23
0.69 19.49
31,516
536,908
US$ 2.270M
US$ 0.21
0.00 0.00
0
10.59M
US$ 2.220M
US$ 0.23
0.0015 0.65
2.01M
8.00M
US$ 1.870M
US$ 2.38
0.01 0.42
124,393
729,980
US$ 1.740M
US$ 0.47
0.00 0.00
0
3.20M
US$ 1.520M
US$ 0.08
0.00 0.00
0
16.67M
US$ 1.370M
US$ 0.96
-0.03 -3.03
17,297
962,637
US$ 924K
US$ 1.61
-0.02 -1.23
85,704
552,854
US$ 890K
US$ 0.03
0.00 0.00
0
25.04M
US$ 851K
US$ 0.07
0.00 0.00
0
7.26M
US$ 508K
US$ 1.15
0.00 0.00
0
418,049
US$ 481K
C$ 0.005
0.00 0.00
0
59.81M
C$ 299K
US$ 0.06
0.00 0.00
0
1.78M
US$ 100K
US$ 0.00
0.00 0.00
0
29.91M
US$ -
US$ 0.00
0.00 0.00
0
40.35M
US$ -
US$ 0.00
0.00 0.00
0
15.85M
US$ -
US$ 0.00
0.00 0.00
0
6.39M
US$ -
US$ 0.00
-0.0001 -100.00
20.55M
855.04M
US$ -
C$ 0.41
0.00 0.00
80,012
-
C$ -
US$ 0.00
0.00 0.00
0
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -

Latest News From Medical Stocks


NuGen Medical Devices: InsuJet Distribution Expands Across France

NuGen Medical Devices Launches French InsuJet(TM) e-Commerce Platform, Delivering Needle-Free Insulin with On-Demand Clinical Support Toronto, Ontario--(Newsfile Corp. - July 7, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, today unveiled www.insujet.fr — a dedicated French-language information and e-commerce site for InsuJet™, the Company's needle-free insulin-delivery... Read more


Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle. Building on the long-standing success and performance of the best-in-class anchor fixation strength of the Q-FIX Family versus competitive devices*, the new Q-FIX KNOTLESS All-Suture Anchor raises the bar for all-suture... Read more


Bio-Rad Laboratories Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

HERCULES, Calif. / Jul 07, 2025 / Business Wire / Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum™ ddPCR system along with the QX700™ series of ddPCR platforms acquired as part of the company’s recently completed acquisition of digital PCR developer... Read more


Inspira Technologies in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

RA'ANANA, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it is engaged in high-level talks with a government health authority, located outside of the United States, which are intended to advance the national integration of its FDA-cleared ART100 system as a foundational component... Read more


Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

LumiThera’s photobiomodulation (PBM) device is the first and only technology that has demonstrated meaningful visual improvement with two years of treatments* in early and intermediate dry AMD patients1,2 Nearly 200 million people globally live with dry AMD, a progressive disease with no cure, and a leading cause of blindness in developed nations3,4 Alcon aims to expand PBM office-based treatment in approved markets, underscoring its commitment to people living with... Read more


Allurion Technologies Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

Fourth and final module of the PMA submitted in June Supportive analyses included in final module of the PMA meet both of the pre-specified co-primary endpoints in the AUDACITY Study NATICK, Mass. / Jul 07, 2025 / Business Wire / Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced submission of the fourth and final module of the Pre-Market Approval (PMA) application to the Food & Drug Administration (FDA) and... Read more


Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a full-service durable medical equipment (“DME”) provider, which is wholly owned by Ballad Health (the “Acquiree”). Ballad Health is a prominent integrated health system comprised of 20 hospitals, post-acute care and... Read more


Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer

AUSTIN, Texas / Jul 07, 2025 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its tissue-free Latitude™ MRD assay, which were presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI). The clinical performance of the assay was analyzed in a cohort of ~200 patients (>1,300 plasma samples) with resectable stage I-IV colorectal cancer.... Read more


Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labeling for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The updated labeling now includes approval for the system in the treatment of... Read more


BioNxt Solutions' Sublingual Cladribine Program for MS Ready for Next Phase

VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT) (OTC:XPHYF) (FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the receipt of the active pharmaceutical ingredient (API) for its lead product candidate, BNT23001. This proprietary sublingual thin-film formulation of cladribine is being developed for the treatment of multiple sclerosis (MS). The delivery of the... Read more


Becton Dickinson Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment

FRANKLIN LAKES, N.J., July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strategy. Mushin will serve as a member of the BD Executive Leadership... Read more


Baxter Appoints Andrew Hider Chief Executive Officer

DEERFIELD, Ill. / Jul 07, 2025 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February... Read more


Merit Medical Systems Names Martha Aronson as New President and Chief Executive Officer

Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit’s new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain... Read more


iRhythm Technologies Announces Board Member Retirements and New Director Appointments

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors. Mark Rubash has served on the... Read more


QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as... Read more


CapsoVision Announces Closing of Initial Public Offering

SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsule endoscopy solutions, today announced the closing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $5.00 per share. The shares began trading on the Nasdaq Capital Market on July 2,... Read more


IceCure Medical Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025

CAESAREA, Israel, July 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced preliminary financial results as of and for the three and six months ended June 30, 2025. The Company expects product sales of approximately $525,000 for the three months ended June 30,... Read more


MDxHealth Appoints Michael Holder to Board of Directors and Announces Management Change

IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May. Mr. Holder is a highly accomplished executive with over 30 years of diverse experience, including nine board,... Read more


Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in children. This inaugural enrollment marks the focused effort to measure the ongoing, real-world... Read more


Intuitive’s da Vinci 5 Surgical System Receives CE Mark

Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic... Read more


Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

RA'ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside... Read more


Biomerica: InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® IBS provides personalized identification of food triggers to substantially improve IBS-related symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company... Read more


Medical City Dallas Hospital Adopts Perimeter Medical Imaging AI's Innovative OCT Imaging Technology for Surgery

Deployment follows participation in pivotal trial of Perimeter's next-gen technology with AI for breast-conserving surgeries TORONTO and DALLAS, July 2, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced today that Medical City Dallas Hospital, an award-winning 899-bed acute care hospital in the Dallas-Fort Worth area, has adopted the company's current... Read more


CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update on its marketing applications for DrugSorb™-ATR with the U.S. Food and Drug Administration (FDA) and Health Canada.  DrugSorb-ATR is an FDA-designated Breakthrough Device designed to reduce the severity of bleeding... Read more


FONAR Board of Directors Appoints Independent Director

Melville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. The Company is very grateful for Ms. Chan's years of service and loyalty to FONA... Read more


Nuwellis Appoints John Erb as Chief Executive Officer

WHO WHAT WHERE WHEN HOW John Erb Appointed as Chief Executive Officer (no longer serving in an interim capacity) Nuwellis Headquarters Effective June 27, 2025 Appointment confirmed by the Board of Directors following his interim leadership MINNEAPOLIS, July 02, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to advancing solutions in fluid management, today announced the appointment of John Erb as... Read more


Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD

AUSTIN, Texas / Jul 01, 2025 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced new data that will be presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI) in Barcelona, Spain. These presentations reinforce the strong clinical and economic utility of Signatera™ monitoring across colon and rectal cancers (CRC), as well as new clinical validation data on its tissue-free MRD assay. Signatera... Read more


First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of initial clinical results using the MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. Titled “First In‑Human Results of the MAGiC Robotic Magnetic Navigation Radiofrequency Ablation Catheter,” the publication is the first peer-reviewed literature... Read more


Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

Milestone expands global reach and reinforces commitment to accessible, first-line infertility solutions -- ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products announces the achievement of regulatory approvals in Australia and New Zealand for its next-generation... Read more


ReShape Lifesciences Granted U.S. Patent Related to an Intragastric Balloon System

Patent Enhances and Broadens the Company’s Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on July 8, 2025 the U.S. Patent and Trademark Office (USPTO) will issue U.S. Patent 12,350,179, entitled, “Intragastric Device.” The patent, related... Read more


Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced that its VidaSleep™ oral appliance, featuring Vivos’... Read more


Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

White Bear Lake, Minnesota--(Newsfile Corp. - July 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of three new patents, further strengthening its intellectual property portfolio in Australia. The Australian Patent Office has issued the following three patents to Envoy Medical Corporation: Australian Patent No. 2021391396 on April... Read more


Nano-X Imaging Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC

Nanox.ARC delivers advanced 3D imaging with proprietary cold cathode technology Clinical studies show superior diagnostic performance to X-ray with reduced radiation exposure compared to CT PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and educational collaboration with Keiser University, Florida’s largest private, non-profit... Read more


New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices

The EluPro BioEnvelope findings demonstrate the bioactive properties and superior healing response compared to synthetic materials for cardiac implantable electronic devices (CIEDs)  GAITHERSBURG, Md., July 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the publication of a new study describing the bioinductive effects of its antibiotic-eluting CIED... Read more


Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025

TTFields therapy concomitant with gemcitabine and nab-paclitaxel demonstrated a statistically significant and clinically meaningful benefit across multiple measures of pain and in a post-hoc analysis significantly delayed the need for opioid pain medication for patients with unresectable, locally advanced pancreatic adenocarcinoma A significant delay in deterioration across measures of health status was observed, preserving quality of life longer in patients treated with... Read more


Zynex Announces Steven Dyson as New CEO

ENGLEWOOD, Colo., June 30, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Steven Dyson as Chief Executive Officer. His employment will begin on August 18, 2025. Thomas Sandgaard, Founder of Zynex and Chairman of the Board since the company's inception in 1996, will remain actively... Read more


INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute

MIDDLETON, Wis. and SARASOTA, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, is excited to announce the addition of Platelet-Rich Plasma (PRP) therapy to its comprehensive suite of fertility services at its Wisconsin Fertility Institute center. This cutting-edge treatment offers additional options for individuals and couples facing fertility challenges,... Read more


Autonomix Medical Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Expansion of study into additional indications doubles the potential addressable market beyond pancreatic cancer pain PoC 2 phase builds on early success and positive results demonstrated in PoC 1 in patients with severe pancreatic cancer pain, supporting multi-indication growth strategy THE WOODLANDS, TX, June 30, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative... Read more


Spectral AI Announces Submission to FDA of its DeepView® System

DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and artificial intelligence (“AI”) algorithms to predict burn healing potential, today announced the submission of its De Novo 510k marketing clearance application to the... Read more


NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

FORT MYERS, Fla. / Jun 30, 2025 / Business Wire / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PanTracer™ Tissue, a next-generation solid tumor profiling assay, including the option to add testing for homologous recombination deficiency (HRD). These new options can provide faster, actionable insights to help physicians navigate complex treatment decisions more confiden... Read more


Bone Biologics Announces Closing of $5.0 Million Public Offering

BURLINGTON, Mass. / Jun 30, 2025 / Business Wire / Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 1,250,000 shares of its common stock (or common stock equivalents in lieu thereof), Series D warrants to purchase up to 1,250,000 shares of common stock and Series E short-term... Read more


Vicarious Surgical Announces Election of New Directors

WALTHAM, Mass. / Jun 30, 2025 / Business Wire / Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the election of Fuad Ahmad and Joseph Doherty to the Vicarious Surgical Board of Directors at the Company’s 2025 Annual Meeting of Stockholders held on June 27, 2025. The Company also announced the departure of Ric Fulop from the Vicarious... Read more


RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of... Read more


Autonomix Medical Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market opportunity and expands Autonomix’s growing global IP portfolio with over 80 issued patents THE WOODLANDS, TX, June 27, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing... Read more


Bone Biologics Files Patent Application for Bone Regeneration Technology

BURLINGTON, Mass. / Jun 27, 2025 / Business Wire / Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark Office (USPTO) for its novel NELL-1 protein. The patent application is directed to compositions of rhNELL-1 polypeptide and uses thereof for treating bone conditions. “This patent... Read more


bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference

SAN ANTONIO / Jun 26, 2025 / Business Wire / bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics and targeted therapeutics, will present findings today related to the discovery of a potential broad-spectrum cancer therapy that is the subject of the Company’s recently issued U.S. Patent No. 12,305,171 and the notification of patent grant from the China National Intellectual Property Administration. The presentation... Read more


Ocumetics Technology Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens

Calgary, Alberta – TheNewswire - June 26, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce the successful completion of a virtual site initiation visit at its clinical partner site in Mexico City. This critical milestone confirms that the investigative site is fully prepared to conduct the upcoming first-in-human (FIH) clinical study of its... Read more


DarioHealth and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide

Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ('Dario' or the 'Company'), a leader in the global digital health market, today announced a strategic commercial agreement with GreenKey Health ('GreenKey'), an innovator in value-based sleep health solutions, to bring... Read more


New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and Adenoids in Children LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced that the European Journal of Pediatrics has published the results of a groundbreaking... Read more


NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

ENvue Targeting $10 Billion+ Market Opportunity with Scalable AI-Enhanced Clinical Robotics TYLER, Texas / Jun 26, 2025 / Business Wire / NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the official launch of a next-generation robotic development initiative within its ENvue Medical (“ENvue” or “ENvue Medical”) division. The new platform,... Read more